Total Payments
$2,328
2024 Payments
$304.22
Companies
39
Transactions
159
Medicare Patients
9,216
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$2,257 (97.0%)
Education$70.27 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,257 | 154 | 97.0% |
| Education | $70.27 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $367.45 | 11 | $0 (2024) |
| PFIZER INC. | $361.29 | 40 | $0 (2022) |
| Janssen Biotech, Inc. | $315.05 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $290.80 | 20 | $0 (2024) |
| Foundation Medicine, Inc. | $89.02 | 2 | $0 (2021) |
| TAIHO ONCOLOGY, INC. | $85.81 | 5 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $65.32 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $54.00 | 4 | $0 (2024) |
| GENZYME CORPORATION | $51.91 | 3 | $0 (2023) |
| Mirati Therapeutics, Inc. | $49.82 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $304.22 | 18 | Novartis Pharmaceuticals Corporation ($59.94) |
| 2023 | $152.83 | 9 | Novartis Pharmaceuticals Corporation ($39.12) |
| 2022 | $125.29 | 9 | Daiichi Sankyo Inc. ($27.62) |
| 2021 | $297.85 | 12 | Daiichi Sankyo Inc. ($113.42) |
| 2020 | $230.15 | 13 | Novartis Pharmaceuticals Corporation ($57.08) |
| 2019 | $669.32 | 49 | PFIZER INC. ($141.49) |
| 2018 | $373.70 | 37 | Janssen Biotech, Inc. ($107.88) |
| 2017 | $174.30 | 12 | Janssen Biotech, Inc. ($40.54) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 10/24/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Oncology | ||||||
| 09/12/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Oncology | ||||||
| 08/22/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Immunology | ||||||
| 06/07/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Oncology | ||||||
| 05/28/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: SURGERY | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Oncology | ||||||
| 03/30/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Oncology | ||||||
| 03/27/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Oncology | ||||||
| 03/21/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Oncology | ||||||
| 03/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Immunology | ||||||
| 01/26/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.98 | General |
| 01/16/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Oncology | ||||||
| 11/27/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Oncology | ||||||
| 10/06/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 06/22/2023 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: BioOncology | ||||||
| 04/17/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Oncology | ||||||
| 03/06/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,778 | 43,505 | $685,263 | $230,212 |
| 2022 | 34 | 2,315 | 64,660 | $2.7M | $1.0M |
| 2021 | 40 | 2,934 | 44,705 | $872,411 | $315,775 |
| 2020 | 33 | 2,189 | 34,181 | $800,167 | $268,637 |
Total Patients
9,216
Total Services
187,051
Medicare Billing
$1.9M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 504 | $81,648 | $45,610 | 55.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 27 | 2,460 | $93,060 | $44,888 | 48.2% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 21 | 32,250 | $129,000 | $28,313 | 21.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 29 | 240 | $85,200 | $23,057 | 27.1% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 15 | 2,840 | $76,680 | $17,319 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 241 | $25,064 | $15,367 | 61.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 385 | 1,149 | $20,682 | $9,652 | 46.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 366 | 986 | $40,426 | $7,478 | 18.5% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 16 | 74 | $5,180 | $5,165 | 99.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $10,540 | $4,596 | 43.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 26 | 190 | $17,100 | $4,152 | 24.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 32 | 83 | $13,280 | $3,872 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 50 | $5,750 | $3,130 | 54.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $7,260 | $3,019 | 41.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 31 | $4,960 | $2,920 | 58.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 55 | 64 | $4,736 | $2,413 | 50.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $3,995 | $2,237 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,975 | $1,602 | 40.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 170 | $7,140 | $1,559 | 21.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 75 | $4,125 | $848.35 | 20.6% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 15 | 82 | $3,280 | $787.60 | 24.0% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 11 | 25 | $3,250 | $609.18 | 18.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 27 | 88 | $3,080 | $557.92 | 18.1% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 27 | 88 | $1,760 | $327.36 | 18.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 73 | $2,044 | $306.60 | 15.0% |
About Dr. Leann Fox, MD
Dr. Leann Fox, MD is a Hematology & Oncology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285639609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leann Fox, MD has received a total of $2,328 in payments from pharmaceutical and medical device companies, with $304.22 received in 2024. These payments were reported across 159 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,257).
As a Medicare-enrolled provider, Fox has provided services to 9,216 Medicare beneficiaries, totaling 187,051 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Jacksonville, FL
- Active Since 06/14/2005
- Last Updated 06/06/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1285639609
Products in Payments
- INJECTAFER (Drug) $349.08
- DARZALEX (Biological) $240.39
- XTANDI (Drug) $120.39
- ELIQUIS (Drug) $96.24
- FOUNDATIONONE (Device) $89.02
- IBRANCE (Drug) $73.67
- MEKINIST (Drug) $60.90
- IMBRUVICA (Drug) $60.39
- LONSURF (Drug) $53.09
- INLYTA (Drug) $52.65
- KRAZATI (Drug) $49.82
- Fabhalta (Drug) $39.69
- KISQALI (Drug) $39.42
- SUTENT (Drug) $39.30
- Lenvima (Drug) $39.01
- XARELTO (Drug) $38.79
- RYBREVANT (Drug) $36.75
- Cabometyx (Drug) $36.14
- PROMACTA (Drug) $35.52
- PIQRAY (Drug) $33.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Jacksonville
Arnab Basu, Md, MD
Hematology & Oncology — Payments: $345,058
Hematology & Oncology $345,058
Edith Perez, Md, MD
Hematology & Oncology — Payments: $282,574
Hematology & Oncology $282,574
Saranya Chumsri, Md, MD
Hematology & Oncology — Payments: $259,129
Hematology & Oncology $259,129
Sikander Ailawadhi, Md, MD
Hematology & Oncology — Payments: $244,554
Hematology & Oncology $244,554
James Foran, Md, MD
Hematology & Oncology — Payments: $157,939
Hematology & Oncology $157,939
Dr. Gregory Pennock, Md, MD
Hematology & Oncology — Payments: $133,778
Hematology & Oncology $133,778